<DOC>
	<DOCNO>NCT01863953</DOCNO>
	<brief_summary>This safety efficacy study fixed-combination bimatoprost brimonidine compare LUMIGAN® ALPHAGAN® patient chronic glaucoma ocular hypertension .</brief_summary>
	<brief_title>A Safety Efficacy Study Fixed-Combination Bimatoprost Brimonidine Chronic Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Diagnosis ocular hypertension glaucoma Requires intraocular pressure ( IOP ) lower therapy Cataract surgery one eye Ocular laser intraocular surgery within 6 month Refractive surgery either eye Anticipated use contact lenses study Expected use artificial tear study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>